Absci (ABSI) Total Current Liabilities (2020 - 2026)

Absci (ABSI) posted Total Current Liabilities of $20.0 million for Q1 2026, down 12.01% sequentially from $22.8 million in Q4 2025, and down 26.58% YoY from $27.3 million in Q1 2025.

Absci (ABSI) Total Current Liabilities (2020 - 2026) Analysis & Trends

Absci has reported Total Current Liabilities for 7 years, with the latest figure at $20.0 million in Q1 2026.

  • Quarterly Total Current Liabilities fell 26.58% year-over-year to $20.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.0 million (down 26.58% YoY) and the FY2025 annual result came in at $22.8 million, down 20.56% from the prior year.
  • Total Current Liabilities fell to $20.0 million in Q1 2026 per ABSI's latest filing, from $22.8 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $41.9 million in Q1 2022 and troughed at $20.0 million in Q1 2026.
  • A 5-year average of $28.3 million and a median of $28.0 million in 2023 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2023 and 2025: Total Current Liabilities sank 35.05% in 2023, then gained 22.99% in 2025.
  • Over 5 years, Total Current Liabilities stood at $30.3 million in 2022, then decreased by 2.35% to $29.6 million in 2023, then declined by 3.05% to $28.7 million in 2024, then dropped by 20.56% to $22.8 million in 2025, then decreased by 12.01% to $20.0 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $20.0 million, $22.8 million, and $29.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.58 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 354.06 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 2.12 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 4.22 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 630.93 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.51 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 438.74 Mn
10 Absci 1.58 Bn 1.37 Bn - 19.60 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 19.60 Mn
Mar 31, 2026 20.03 Mn
Dec 31, 2025 22.77 Mn
Sep 30, 2025 29.71 Mn
Jun 30, 2025 31.32 Mn
Mar 31, 2025 27.28 Mn
Dec 31, 2024 28.66 Mn
Sep 30, 2024 26.69 Mn
Jun 30, 2024 25.47 Mn
Mar 31, 2024 25.29 Mn
Dec 31, 2023 29.56 Mn
Sep 30, 2023 27.97 Mn
Jun 30, 2023 25.48 Mn
Mar 31, 2023 27.20 Mn
Dec 31, 2022 30.27 Mn
Sep 30, 2022 30.03 Mn
Jun 30, 2022 31.69 Mn
Mar 31, 2022 41.88 Mn
Dec 31, 2021 33.86 Mn
Sep 30, 2021 30.25 Mn